<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="8325" end="8329" sStart="8286" offset="39" sid="r7.1.use.v.0993" wn="1" wnkey="use%2:34:01::" text="Aliquots of the pooled cells used for cloning were also plated in triplicate, treated with GS-E or DMSO for 24 hrs." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="3839" end="3844" sStart="null" offset="0" sid="r7.1.use.v.0609" wn="1" wnkey="use%2:34:01::" text="Using these plasmids as a starting point, a novel indicator of the inducible gene expression system was constructed as follows." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="6986" end="6990" sStart="null" offset="56" sid="r7.1.use.v.0820" wn="1" wnkey="use%2:34:01::" text="This clone, designated MBT2+RheoSwitch-2, was used for further development." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="8945" end="8956" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="Eighty-four luciferase transfected clones and 113 SEAP transfected clones were &lt;b&gt;transferred&lt;/b&gt; from the 96 well plates and duplicate wells of each were treated with either DMSO or 15 ?M GS-E in DMSO for 24 hours." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6750-1-11.anc" start="14257" end="14262" sStart="null" offset="0" sid="null" wn="5" wnkey="show%2:36:00::" text="No change was seen in the level of the internal control Renilla luciferase with varying concentrations of GS-E (raw data not &lt;b&gt;shown&lt;/b&gt; but effect accounted for in the calculation as defined above)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6750-1-11.anc" start="14257" end="14262" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="No change was seen in the level of the internal control Renilla luciferase with varying concentrations of GS-E (raw data not &lt;b&gt;shown&lt;/b&gt; but effect accounted for in the calculation as defined above)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6750-1-11.anc" start="14257" end="14262" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="No change was seen in the level of the internal control Renilla luciferase with varying concentrations of GS-E (raw data not &lt;b&gt;shown&lt;/b&gt; but effect accounted for in the calculation as defined above)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6750-1-11.anc" start="14257" end="14262" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="No change was seen in the level of the internal control Renilla luciferase with varying concentrations of GS-E (raw data not &lt;b&gt;shown&lt;/b&gt; but effect accounted for in the calculation as defined above)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6750-1-11.anc" start="14257" end="14262" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="No change was seen in the level of the internal control Renilla luciferase with varying concentrations of GS-E (raw data not &lt;b&gt;shown&lt;/b&gt; but effect accounted for in the calculation as defined above)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6750-1-11.anc" start="14257" end="14262" sStart="null" offset="0" sid="null" wn="5" wnkey="show%2:36:00::" text="No change was seen in the level of the internal control Renilla luciferase with varying concentrations of GS-E (raw data not &lt;b&gt;shown&lt;/b&gt; but effect accounted for in the calculation as defined above)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="26216" end="26221" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Finally, due to the &lt;b&gt;rapid&lt;/b&gt; decay of gene expression following maximal activation, this system can be easily titrated for the duration of the induction necessary by using slow release formulations such as ALZET mini pumps [ 18 ] . The postgenomic era has accentuated the need to develop methods to determine in vivo gene function in cancer and this ecdysone system may be a useful approach to address this." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="21794" end="21799" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The strengths of the ecdysone-inducible system appear to be its tight regulation, its dose responsiveness, and the favorable uptake and clearance kinetics of the inducer, which results in &lt;b&gt;rapid&lt;/b&gt; gene switching." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="26216" end="26221" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Finally, due to the &lt;b&gt;rapid&lt;/b&gt; decay of gene expression following maximal activation, this system can be easily titrated for the duration of the induction necessary by using slow release formulations such as ALZET mini pumps [ 18 ] . The postgenomic era has accentuated the need to develop methods to determine in vivo gene function in cancer and this ecdysone system may be a useful approach to address this." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="26113" end="26118" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="We have presented data that is the first demonstration of tumor cell lines stably transfected with an ecdysone inducible constructs tested in vivo demonstrating that in vivo these constructs coupled with GS-E allow &lt;b&gt;rapid&lt;/b&gt; and robust induction of gene expression in tumor xenografts." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="22110" end="22115" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="In vitro data indicates that our constructs when used in combination with GS-E, offer an excellent induction profile and &lt;b&gt;rapid&lt;/b&gt; decay of gene expression when the compound is removed from in vitro culture." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="18499" end="18504" sStart="null" offset="0" sid="null" wn="2" wnkey="rapid%5:00:02:fast:01" text="Methods devised to control gene expression must allow for &lt;b&gt;rapid&lt;/b&gt;, robust, precise, and reversible induction of gene activity." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="21794" end="21799" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The strengths of the ecdysone-inducible system appear to be its tight regulation, its dose responsiveness, and the favorable uptake and clearance kinetics of the inducer, which results in &lt;b&gt;rapid&lt;/b&gt; gene switching." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="26216" end="26221" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Finally, due to the &lt;b&gt;rapid&lt;/b&gt; decay of gene expression following maximal activation, this system can be easily titrated for the duration of the induction necessary by using slow release formulations such as ALZET mini pumps [ 18 ] . The postgenomic era has accentuated the need to develop methods to determine in vivo gene function in cancer and this ecdysone system may be a useful approach to address this." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="26113" end="26118" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="We have presented data that is the first demonstration of tumor cell lines stably transfected with an ecdysone inducible constructs tested in vivo demonstrating that in vivo these constructs coupled with GS-E allow &lt;b&gt;rapid&lt;/b&gt; and robust induction of gene expression in tumor xenografts." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="26216" end="26221" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Finally, due to the &lt;b&gt;rapid&lt;/b&gt; decay of gene expression following maximal activation, this system can be easily titrated for the duration of the induction necessary by using slow release formulations such as ALZET mini pumps [ 18 ] . The postgenomic era has accentuated the need to develop methods to determine in vivo gene function in cancer and this ecdysone system may be a useful approach to address this." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="26216" end="26221" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Finally, due to the &lt;b&gt;rapid&lt;/b&gt; decay of gene expression following maximal activation, this system can be easily titrated for the duration of the induction necessary by using slow release formulations such as ALZET mini pumps [ 18 ] . The postgenomic era has accentuated the need to develop methods to determine in vivo gene function in cancer and this ecdysone system may be a useful approach to address this." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="20353" end="20358" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The popularity of the ecdysone-inducible gene switch led to the unexpected &lt;b&gt;rapid&lt;/b&gt; depletion of murA stocks, the primary inducer used in the system." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="26216" end="26221" sStart="null" offset="0" sid="null" wn="2" wnkey="rapid%5:00:02:fast:01" text="Finally, due to the &lt;b&gt;rapid&lt;/b&gt; decay of gene expression following maximal activation, this system can be easily titrated for the duration of the induction necessary by using slow release formulations such as ALZET mini pumps [ 18 ] . The postgenomic era has accentuated the need to develop methods to determine in vivo gene function in cancer and this ecdysone system may be a useful approach to address this." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="22110" end="22115" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="In vitro data indicates that our constructs when used in combination with GS-E, offer an excellent induction profile and &lt;b&gt;rapid&lt;/b&gt; decay of gene expression when the compound is removed from in vitro culture." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="18499" end="18504" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Methods devised to control gene expression must allow for &lt;b&gt;rapid&lt;/b&gt;, robust, precise, and reversible induction of gene activity." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="1864" end="1870" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="The ecdysone hormones do not affect mammalian physiology like glucocorticoids or progestins and are not known to be toxic or teratogenic like tetracycline [ 11 ] allowing their use in both developmental studies with transgenic animals as well as in the context of gene therapy and tumor biology studies in &lt;b&gt;mature&lt;/b&gt; animals." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="1864" end="1870" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="The ecdysone hormones do not affect mammalian physiology like glucocorticoids or progestins and are not known to be toxic or teratogenic like tetracycline [ 11 ] allowing their use in both developmental studies with transgenic animals as well as in the context of gene therapy and tumor biology studies in &lt;b&gt;mature&lt;/b&gt; animals." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="1864" end="1870" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="The ecdysone hormones do not affect mammalian physiology like glucocorticoids or progestins and are not known to be toxic or teratogenic like tetracycline [ 11 ] allowing their use in both developmental studies with transgenic animals as well as in the context of gene therapy and tumor biology studies in &lt;b&gt;mature&lt;/b&gt; animals." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="1864" end="1870" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="The ecdysone hormones do not affect mammalian physiology like glucocorticoids or progestins and are not known to be toxic or teratogenic like tetracycline [ 11 ] allowing their use in both developmental studies with transgenic animals as well as in the context of gene therapy and tumor biology studies in &lt;b&gt;mature&lt;/b&gt; animals." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12157" end="12163" sStart="null" offset="105" sid="r9.level.n.0474" wn="1" wnkey="level%1:07:00::" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="4253" end="4257" sStart="null" offset="137" sid="r9.late.j.0763" wn="2147483646" wnkey="null" text="Inserted in its place were five copies of the GAL4 binding site followed by the minimal promoter region of the major late promoter from adenovirus (from pG5-luc (Promega)) and the coding region for the enhanced green fluorescent protein (EGFP) gene (from pEGFP-N1) (Clontech)." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="31380" end="31384" sStart="null" offset="103" sid="r10.high.j.0695" wn="1" wnkey="high%3:00:02::" text="Clones exhibiting low background luciferase expression prior to addition of the compound and high levels following the addition were selected for further in vivo and in vitro study." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="6369" end="6373" sStart="null" offset="41" sid="r10.high.j.0706" wn="1" wnkey="high%3:00:02::" text="Four clones of each cell line exhibiting high levels of EGFP expression were expanded for further analysis." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="4648" end="4652" sStart="null" offset="47" sid="r10.high.j.0174" wn="1" wnkey="high%3:00:02::" text="This plasmid provides constitutively high gene expression and we use it as an indicator of the number of tumor cells present in the tissue samples harvested from mice in the in vivo experiments." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="26555" end="26563" sStart="null" offset="359" sid="r11.function.n.0233" wn="2" wnkey="function%1:07:00::" text="Finally, due to the rapid decay of gene expression following maximal activation, this system can be easily titrated for the duration of the induction necessary by using slow release formulations such as ALZET mini pumps [ 18 ] . The postgenomic era has accentuated the need to develop methods to determine in vivo gene function in cancer and this ecdysone system may be a useful approach to address this." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="21113" end="21121" sStart="null" offset="153" sid="r11.function.n.0116" wn="2" wnkey="function%1:07:00::" text="The avalanche of new genes resulting from completion of the genome project has accentuated the need to develop methods to determine gene function." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12859" end="12863" sStart="null" offset="102" sid="null" wn="1" wnkey="fold%2:35:00::" text="Data were plotted as a GS-E (RLU1/RLU2)/Control (RLU1/RLU2) ratio (as in Table 1) fold induction over the 0 time point which was set empirically as 1. This data shown in Figure 3Aindicates that gene expression is increased by 8 hours and reaches maximum induction by 24 hours." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12341" end="12345" sStart="null" offset="289" sid="null" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12231" end="12235" sStart="null" offset="179" sid="null" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="6867" end="6871" sStart="null" offset="17" sid="r9.fold.v.0317" wn="2147483645" wnkey="null" text="Clone #2 had 8.4-fold higher luciferase activity with GS-E treatment." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12859" end="12863" sStart="null" offset="102" sid="null" wn="2147483645" wnkey="null" text="Data were plotted as a GS-E (RLU1/RLU2)/Control (RLU1/RLU2) ratio (as in Table 1) fold induction over the 0 time point which was set empirically as 1. This data shown in Figure 3Aindicates that gene expression is increased by 8 hours and reaches maximum induction by 24 hours." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12341" end="12345" sStart="null" offset="289" sid="null" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12231" end="12235" sStart="null" offset="179" sid="null" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12859" end="12863" sStart="null" offset="102" sid="null" wn="2147483644" wnkey="null" text="Data were plotted as a GS-E (RLU1/RLU2)/Control (RLU1/RLU2) ratio (as in Table 1) fold induction over the 0 time point which was set empirically as 1. This data shown in Figure 3Aindicates that gene expression is increased by 8 hours and reaches maximum induction by 24 hours." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12341" end="12345" sStart="null" offset="289" sid="null" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12231" end="12235" sStart="null" offset="179" sid="null" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12231" end="12235" sStart="null" offset="179" sid="r9.fold.v.0835" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="16030" end="16034" sStart="null" offset="2" sid="r9.fold.v.0367" wn="2147483645" wnkey="null" text="2-fold induction over DMSO)." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="7132" end="7136" sStart="null" offset="116" sid="r9.fold.v.0183" wn="2147483645" wnkey="null" text="In a similar analysis, Panc02+RheoSwitch-3 and -4 demonstrated induction levels of 366- and 428-fold respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12859" end="12863" sStart="null" offset="102" sid="null" wn="2147483645" wnkey="null" text="Data were plotted as a GS-E (RLU1/RLU2)/Control (RLU1/RLU2) ratio (as in Table 1) fold induction over the 0 time point which was set empirically as 1. This data shown in Figure 3Aindicates that gene expression is increased by 8 hours and reaches maximum induction by 24 hours." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12341" end="12345" sStart="null" offset="289" sid="null" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12231" end="12235" sStart="null" offset="179" sid="null" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="15922" end="15926" sStart="null" offset="2" sid="r9.fold.v.0864" wn="2147483645" wnkey="null" text="5-fold induction over DMSO treatment alone) and a maximal induction with 15 ?M GS-E (80." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="13828" end="13832" sStart="null" offset="100" sid="r9.fold.v.0820" wn="2147483645" wnkey="null" text="Data were plotted as a GS-E(RLU1/RLU2)/Control(RLU1/RLU2) ratio (as in Table 1) fold induction over the 0 drug concentration which was set empirically as 1. These results show an increase in gene inducing activity with increasing GS-E concentrations up to 10 ?M." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="10660" end="10664" sStart="null" offset="213" sid="r9.fold.v.0684" wn="2147483645" wnkey="null" text="Multiple assays in triplicate on the GAL4-SEAP transfected clones gave induction levels ranging from 118- to 551-fold for the best five Panc02+RHeoSwitch-3 clones and from 52- to 486-fold for the best twelve Panc02+RHeoSwitch-4 clones." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="10580" end="10584" sStart="null" offset="133" sid="r9.fold.v.0516" wn="2147483645" wnkey="null" text="Multiple assays in triplicate on the GAL4-SEAP transfected clones gave induction levels ranging from 118- to 551-fold for the best five Panc02+RHeoSwitch-3 clones and from 52- to 486-fold for the best twelve Panc02+RHeoSwitch-4 clones." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12859" end="12863" sStart="null" offset="102" sid="null" wn="2147483645" wnkey="null" text="Data were plotted as a GS-E (RLU1/RLU2)/Control (RLU1/RLU2) ratio (as in Table 1) fold induction over the 0 time point which was set empirically as 1. This data shown in Figure 3Aindicates that gene expression is increased by 8 hours and reaches maximum induction by 24 hours." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12341" end="12345" sStart="null" offset="289" sid="null" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12231" end="12235" sStart="null" offset="179" sid="null" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12859" end="12863" sStart="null" offset="102" sid="null" wn="2147483645" wnkey="null" text="Data were plotted as a GS-E (RLU1/RLU2)/Control (RLU1/RLU2) ratio (as in Table 1) fold induction over the 0 time point which was set empirically as 1. This data shown in Figure 3Aindicates that gene expression is increased by 8 hours and reaches maximum induction by 24 hours." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12341" end="12345" sStart="null" offset="289" sid="null" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12231" end="12235" sStart="null" offset="179" sid="null" wn="2147483645" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="12341" end="12345" sStart="null" offset="289" sid="r9.fold.v.0682" wn="" wnkey="null" text="Treatment of luciferase clone 5B3 with 15 ?M GS-E for 48 hours consistently induced luciferase levels from near background with only DMSO added, to nearly 150-fold (Table 1) when adjusted for non specific R-Luc induction which was approximately 1.2 fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="8585" end="8589" sStart="null" offset="163" sid="r9.fold.v.0606" wn="" wnkey="null" text="Assays for the appropriate reporter in each cell pool showed induction ratios of 17-fold for the luciferase transfected cells and 22-fold for the SEAP transfected cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="21169" end="21173" sStart="null" offset="46" sid="r7.1.easy.j.0446" wn="1" wnkey="easy%3:00:01::" text="The requirement for tight regulation, easy titration and minimal background expression is particularly important in the study of genes such as tumor suppressors or cell cycle regulatory genes for which cell lines stably expressing the product can rarely be made." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="4447" end="4454" sStart="null" offset="4" sid="r10.control.n.0389" wn="4" wnkey="control%1:09:02::" text="The control plasmid, pRL-TK (Promega), expresses the Renilla luciferase gene under the control of the HSV thymidine kinase (TK) promoter." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="23345" end="23351" sStart="null" offset="67" sid="r10.common.j.0805" wn="4" wnkey="common%5:00:00:familiar:02" text="First, it was derived by chemical carcinogenesis, the most common known etiologic factor in bladder cancer." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="20730" end="20736" sStart="null" offset="130" sid="r10.common.j.0564" wn="4" wnkey="common%5:00:00:familiar:02" text="[ 10 ] The difficulty in obtaining kaladana seeds prompted efforts to seek alternative inducers derived from more common plants or synthetic analogs such as GS-E." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="22038" end="22049" sStart="null" offset="65" sid="r11.combination.n.0929" wn="1" wnkey="combination%1:14:00::" text="In vitro data indicates that our constructs when used in combination with GS-E, offer an excellent induction profile and rapid decay of gene expression when the compound is removed from in vitro culture." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6750-1-11.anc" start="21824" end="21831" sStart="null" offset="8" sid="r9.appear.v.0129" wn="1" wnkey="appear%2:39:00::" text="Thus it appears ideal for both the in vitro and in vivo study of newly characterized genes in their role in tumor formation and progression." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6750-1-11.anc" start="30319" end="30324" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="GS-E in DMSO was &lt;b&gt;added&lt;/b&gt; to the remaining three wells to a final GS-E concentration of 15 ?M and DMSO concentration of 0.3%." />
  </sentences>
</list>